Revolution Medicines (RVMD) Shares Outstanding (Entity) (2019 - 2026)
Revolution Medicines (RVMD) Shares Outstanding (Entity) (2019 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 254.16 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 200.18 Mn |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 200.18 Mn |
| Dec 31, 2025 | 197.00 Mn |
| Sep 30, 2025 | 189.71 Mn |
| Jun 30, 2025 | 186.90 Mn |
| Mar 31, 2025 | 186.26 Mn |
| Dec 31, 2024 | 185.90 Mn |
| Sep 30, 2024 | 173.31 Mn |
| Jun 30, 2024 | 171.21 Mn |
| Mar 31, 2024 | 170.47 Mn |
| Dec 31, 2023 | 113.15 Mn |
| Sep 30, 2023 | 109.45 Mn |
| Jun 30, 2023 | 109.14 Mn |
| Mar 31, 2023 | 106.30 Mn |
| Dec 31, 2022 | 90.41 Mn |
| Sep 30, 2022 | 87.82 Mn |
| Jun 30, 2022 | 74.46 Mn |
| Mar 31, 2022 | 74.23 Mn |
| Dec 31, 2021 | 74.14 Mn |
| Sep 30, 2021 | 73.65 Mn |
| Jun 30, 2021 | 73.58 Mn |